Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines.
about
NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cellsMediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter.Augmented latent membrane protein 1 expression from Epstein-Barr virus episomes with minimal terminal repeatsDifference in cytokine production and cell cycle progression induced by Epstein-Barr virus Lmp1 deletion variants in Kmh2, a Hodgkin lymphoma cell line.Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expressionEpstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1Signaling activities of gammaherpesvirus membrane proteinsHumoral immune responses to Epstein-Barr virus encoded tumor associated proteins and their putative extracellular domains in nasopharyngeal carcinoma patients and regional controls.Intracellular signaling molecules activated by Epstein-Barr virus for induction of interferon regulatory factor 7.Epstein-Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growthMolecular virology of Epstein-Barr virus.The EBNA2 polyproline region is dispensable for Epstein-Barr virus-mediated immortalization maintenanceLMP1-induced downregulation of CD99 molecules in Hodgkin and Reed-Sternberg cells.EBNA3A association with RBP-Jkappa down-regulates c-myc and Epstein-Barr virus-transformed lymphoblast growth.Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.Modulation of B-cell endoplasmic reticulum calcium homeostasis by Epstein-Barr virus latent membrane protein-1.Epstein-Barr virus latent membrane protein 1 increases calcium influx through store-operated channels in B lymphoid cells.Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway.LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-κB activationLMP1 mediates multinuclearity through downregulation of shelterin proteins and formation of telomeric aggregates.Interferon regulatory factor 7 is activated by a viral oncoprotein through RIP-dependent ubiquitination.The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle blockThe LMP1 oncogene of EBV activates PERK and the unfolded protein response to drive its own synthesis.The promyelocytic leukemia zinc finger protein down-regulates apoptosis and expression of the proapoptotic BID protein in lymphocytesMolecular basis of cytotoxicity of Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency III B cells: LMP1 induces type II ligand-independent autoactivation of CD95/Fas with caspase 8-mediated apoptosis.Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes.Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells.Repression of the proapoptotic cellular BIK/NBK gene by Epstein-Barr virus antagonizes transforming growth factor β1-induced B-cell apoptosis.An update on viral association of human cancers.Nuclear factor-kappaB binds to the Epstein-Barr Virus LMP1 promoter and upregulates its expressionTRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40.CD63 Regulates Epstein-Barr Virus LMP1 Exosomal Packaging, Enhancement of Vesicle Production, and Noncanonical NF-κB Signaling.Constitutive autophagy contributes to resistance to TP53-mediated apoptosis in Epstein-Barr virus-positive latency III B-cell lymphoproliferations.Epstein-Barr virus represses the FoxO1 transcription factor through latent membrane protein 1 and latent membrane protein 2AEpstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.LMP1 and Dynamic Progressive Telomere Dysfunction: A Major Culprit in EBV-Associated Hodgkin's Lymphoma.
P2860
Q22254088-EF7AA484-64F5-4481-9E9E-1758E118B757Q24336304-05B6844B-4CEB-4109-B325-FE6E8D266DF8Q24516975-C42907DC-8B9D-4C41-AE80-F5DB4D120287Q33640213-EFDE418B-6029-44F3-B7A0-86D17FCCFC8CQ33649035-397901CD-31A9-487D-855E-1AEF502A02E0Q33673610-126656BD-DBA7-45F6-AE4B-2716D79223FEQ33784729-B6A306B0-6F5E-4CF0-B7EC-125AB2D92D22Q33787090-FB702C12-7826-49F4-AC21-C83E047A6E19Q33792860-CF207CA8-1A59-4D18-BB8D-C2FEEBFBA512Q33822504-BA2DFD0B-4524-4ED4-A8D2-6630572C6751Q33822681-57274115-DD66-4E2D-952E-99287A0839D3Q33870488-A83D70FA-B08F-4821-B492-6BD4C170B2A0Q33953070-A4756753-6462-42F8-9D55-CA95E4E0EBE0Q34225554-22FE8028-E9B0-44FA-8E4C-1B5453A67CCBQ34341875-7915E8B5-93AB-45B7-B3B2-44785B310A12Q34430225-5684F4F0-B0D4-4EB9-B009-4A1FAB779002Q34465612-933DE88F-57DA-479B-BB09-FC5918C3E065Q34658852-817B1648-E845-442A-B2D9-5E23089D5CB7Q34992494-E57E5A92-C4F2-4822-A325-56F1427F6FECQ34998074-9F11D34A-1806-48A8-BBC5-3CE9F77F0844Q35024009-EDBA8FAA-067D-459B-ACA2-36EBE5382F03Q35052575-A7A1AC08-C339-4A8E-AFA8-18AB6530D03EQ35539719-87AD771C-F472-40EF-A467-48CF007C6A9DQ35856781-90E89526-128F-4C37-9DF4-FC302369536EQ35857290-E68E7EC8-A048-4557-857A-C9B94C9F3519Q36445900-5D16842E-3A9C-4793-9370-E8F05AD6898CQ36603944-7F3CE9B1-4E5E-4102-A916-A05B243074D4Q36747951-52D5C07E-C404-4B42-A7C4-3DB8B81FAC1EQ36933913-BF9FAC64-545F-45B6-8892-97A46F69B87CQ36961875-18CAB99F-7EDA-4F85-A5E0-6C86C011592AQ37093324-C3F2BB3C-D858-4D66-9488-CD2F1FEC8232Q37713998-90195782-10C1-4B99-8454-D7ECE2144797Q38082388-13A40A7B-5AAF-4930-86E3-8956B9B756EAQ38358818-79055C92-8A98-4A0A-A23D-0E5EE0A0DA97Q38359234-D7769E8F-F699-4ADD-B8D5-0B5D12A72067Q38782732-898F6CD0-4E5A-4E11-96E9-AE598F27748DQ38819714-23C843E2-74C1-462C-B365-6393D0ABAFE5Q39304933-D943AD63-E7D4-4822-BF46-E51F32411AE0Q39306073-FF92B0C7-293D-42CA-A356-39E649CA343FQ39400493-BF754A19-021C-4AE1-A2CA-0BEFFF05352F
P2860
Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Cytostatic effect of Epstein-B ...... ed expression in B cell lines.
@en
type
label
Cytostatic effect of Epstein-B ...... ed expression in B cell lines.
@en
prefLabel
Cytostatic effect of Epstein-B ...... ed expression in B cell lines.
@en
P2093
P356
P1433
P1476
Cytostatic effect of Epstein-B ...... ed expression in B cell lines.
@en
P2093
Floettmann JE
Rickinson AB
P356
10.1006/VIRO.1996.0452
P407
P50
P577
1996-09-01T00:00:00Z